Enanta Pharmaceuticals
ENTA
#8622
Rank
A$0.37 B
Marketcap
A$12.92
Share price
-18.56%
Change (1 day)
-34.56%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2026 (TTM): A-$3.56

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$3.58. In 2025 the company made an earnings per share (EPS) of A-$4.76 an increase over its 2024 EPS that were of A-$7.36.

EPS history for Enanta Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$3.56-25.13%
2025A-$4.76-35.35%
2024A-$7.36
2021A-$7.4072.92%
2020A-$4.28-267.44%
2019A$2.56-61.35%
2018A$6.62147.22%
2017A$2.68-460%
2016A-$0.74-114.88%
2015A$5.00-23.81%
2014A$6.56-244.12%
2013A-$4.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.93-377.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.81-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
A$8.70-342.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$23.30-750.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.48-141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.72-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA